Nagaileben Co., Ltd.
Stock Price Chart
2026/10/09 12:26 UpdatedPrice Trend
2026/10/09 12:26 UpdatedPrice & Trading Details
2026/10/09 12:26 UpdatedPRICE
TRADING
Shareholder Composition
Updated 2026/10/01Dividend History
Updated 2026/10/04| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥70 | -30.0% |
| 2025 | ¥100 | +66.7% |
| 2024 | ¥60 | 0.0% |
| 2023 | ¥60 | 0.0% |
| 2022 | ¥60 | - |
Financial Performance
2026/10/04 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥17,745M | ¥17,182M | ¥16,413M | ¥16,984M |
| Gross Profit | ¥7,882M | ¥7,547M | ¥7,029M | ¥6,712M |
| Operating Income | ¥5,032M | ¥4,605M | ¥4,005M | ¥3,583M |
| Pretax Income | ¥5,032M | ¥4,605M | ¥4,005M | ¥3,583M |
| Net Income | ¥3,778M | ¥3,226M | ¥2,822M | ¥2,573M |
| EPS | ¥115.77 | ¥100.04 | ¥88.77 | ¥83.24 |
| Operating Margin | 28.35% | 26.80% | 24.40% | 21.10% |
| Balance Sheet | ||||
| Total Assets | ¥47,348M | ¥47,378M | ¥46,727M | ¥44,692M |
| Total Equity | ¥42,255M | ¥43,214M | ¥42,697M | ¥41,318M |
| Total Liabilities | ¥5,093M | ¥4,164M | ¥4,030M | ¥3,374M |
| Cash | ¥28,561M | ¥27,159M | ¥26,349M | ¥24,246M |
| Interest-bearing Debt | - | - | - | - |
| Equity Ratio | 89.24% | 91.21% | 91.38% | 92.45% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥3,443M | ¥1,813M | ¥2,287M | ¥2,181M |
| Investing CF | -¥471M | ¥3,418M | -¥1,769M | ¥1,110M |
| Financing CF | -¥3,203M | -¥2,935M | -¥2,930M | -¥3,894M |
| Free CF | ¥3,327M | ¥1,528M | ¥2,119M | ¥1,792M |
| Efficiency | ||||
| ROE | 8.94% | 7.47% | 6.61% | 6.23% |
| ROA | 7.98% | 6.81% | 6.04% | 5.76% |
Latest IR Information
-
Financial Summary for Fiscal Year Ended August 2026 and Full-Year Forecast for Fiscal Year Ending August 2027
Revenue increased by +1.3% year-over-year. Full-year forecast is 17,205 hundred million yen (first half: 7,861 hundred million yen); revenue for FY ending August 2027 is expected to rise by +1.7%. Major segments such as surgical wear and overseas markets grew,...
Read more -
Notice of Decision on Matters Concerning Share Buyback
Decided to acquire up to 600,000 shares (equivalent to 2.04% of total outstanding shares) by market purchase, with an aggregate upper limit of 10 hundred million yen. The acquisition period is from 2026/10/2 to 2026/12/31. Will implement agile capital policy...
Read more -
Fiscal Year Ended August 2026 Financial Summary [Japanese GAAP] (Consolidated)
Net sales increased 1.3% year-over-year to 17,205 million yen, operating income was 3,625 million yen, and net income attributable to owners of parent was 2,650 million yen. Forecast for FY ending August 2027: net sales 17,500 million yen, operating income...
Read more -
Notice on Partial Revision of the Internal Control Basic Policy
Partial revision of the Internal Control Basic Policy. Clarifies and strengthens roles related to education, hotline, risk management, and the Audit Committee. Revisions are underlined. Periods and figures are unknown.
Read more -
Notice Regarding Share Buyback Status and Completion
The acquired shares consist of 157,900 common shares, total amount 279,133,900 yen, the period from August 1, 2026 to August 12, acquired through market purchases, with completion disclosed as well
Read more
Latest News (5 items)
Company Information
About
Nagaileben Co., Ltd. manufactures and sells medical clothing in Japan. The company engages in sale, import, and export of various white clothing and hospital shoes and socks. It also offers hospital, clinic, surgical, and nursing facility clothing products, as well as surgical linen. The company was founded in 1915 and is headquartered in Tokyo, Japan.
